Develops customizable nanowire biosensor platforms that enable ultra-sensitive detection of low-abundance biomolecules, improving diagnostic accuracy for diseases. These platforms support next-generation DNA sequencing and molecular biomarker identification, offering up to 8X more genetic information in reduced time and cost compared to current methods.
Funding
$3.3M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Current DNA sequencing and molecular biomarker detection methods often lack the sensitivity needed for early disease diagnosis and therapeutic monitoring, requiring large sample volumes and lengthy processing times. Existing technologies may also fail to capture the full spectrum of genetic information, limiting diagnostic accuracy and predictive capabilities.
Solution
Aligned Bio develops customizable nanowire platforms that significantly enhance the sensitivity of optical, electrochemical, and electrical sensors for DNA sequencing and biomarker detection. Their nanowire-based, long-read DNA sequencer provides up to 8X more genetic information compared to existing methods, while reducing both time and cost. The platform's unique nanowire waveguide technology enables the detection of biomolecules at much lower concentrations than traditional systems. Aligned Bio offers tailored platform development and licensing agreements for their patented nanowire waveguide technology, facilitating seamless integration into existing or new products.
Target Audience
The primary target audience includes companies and research organizations in in vitro diagnostics (IVD), environmental monitoring, wearable biosensors, and next-generation sequencing.
Features
- Customizable nanowire platforms with varying sizes, materials, and spacing
- Nanowire waveguides for improved light-guiding efficiency and signal strength
- Enhanced sensitivity for detecting low-abundance biomolecules
- Compatibility with optical, electrochemical, and electrical sensors
- Long-read DNA sequencing capabilities
- Patented Aerotaxy™ method for producing and aligning nanowires
- Substrate sizes ranging from millimeter to meter scale